Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension

Marco Piastra, Giorgio Conti, Gabriella De Rosa, Maria Pia De Carolis, Iliana Bersani, Manuela Pardeo, Eleonora Stival, Costantino Romagnoli, Alessia Tempera

Research output: Contribution to journalArticle

Abstract

We report the successful and safe use of levosimendan, a new calcium-sensitizing agent with positive inotropic and vasodilatory action, in 2 critically ill term newborns with acute heart failure and pulmonary hypertension in the absence of any underlying heart malformation and/or previous cardiosurgical procedures. During the neonatal period, levosimendan may represent an ideal drug for immature myocardium characterized by a higher calcium-dependent contractility than in adults.
Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalNeonatology
Publication statusPublished - 2011

Keywords

  • ISCHEMIC HEART FAILURE

Fingerprint

Dive into the research topics of 'Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension'. Together they form a unique fingerprint.

Cite this